Olga Pirogova Sells 548 Shares of Azenta, Inc. (NASDAQ:AZTA) Stock

Azenta, Inc. (NASDAQ:AZTA) SVP Olga Pirogova sold 548 shares of Azenta stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total value of $21,958.36. Following the completion of the transaction, the senior vice president now owns 19,373 shares of the company’s stock, valued at approximately $776,276.11. This trade represents a 2.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Azenta Stock Down 0.8 %

Shares of NASDAQ AZTA opened at $45.16 on Friday. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $69.16. The business has a 50-day moving average of $45.22 and a two-hundred day moving average of $50.12.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.13 earnings per share. Equities research analysts anticipate that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC lifted its position in Azenta by 1.9% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock valued at $278,783,000 after acquiring an additional 100,826 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Azenta by 16.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after purchasing an additional 421,719 shares during the last quarter. State Street Corp boosted its position in shares of Azenta by 0.4% in the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock valued at $81,718,000 after purchasing an additional 6,398 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares during the last quarter. Finally, Royce & Associates LP increased its position in Azenta by 7.8% during the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock worth $35,844,000 after buying an additional 53,584 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AZTA. Needham & Company LLC reduced their price target on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Evercore ISI cut their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Azenta presently has a consensus rating of “Hold” and an average price target of $63.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.